Rhinovirus-induced wheeze was associated with asthma development in predisposed children

Idun Holmdahl1,2, Sofia Lüning1,2, Sabina Wärnberg Gerdin1,2

  • 1Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.

Insights

Early rhinovirus-induced wheeze and allergic sensitization are key risk factors for childhood asthma. These factors, combined with hereditary predisposition, significantly increase the likelihood of developing asthma by age 11.

Area of Science:

  • Pediatric Allergy and Immunology
  • Respiratory Medicine
  • Epidemiology

Background:

  • Childhood asthma is a significant public health concern with complex etiological factors.
  • Early-life respiratory infections and allergic sensitization are implicated in asthma development.
  • Understanding the interplay of these factors is crucial for effective prevention and management.

Purpose of the Study:

  • To investigate the association between early-life rhinovirus-induced wheeze and allergic sensitization with asthma development at 11 years of age.
  • To identify key risk factors contributing to the onset of asthma in children.
  • To explore the role of genetic predisposition and environmental factors in asthma etiology.

Main Methods:

  • A cohort of 107 children experiencing acute wheeze (aged 6-48 months) were followed up to 11 years.
  • 46 age-matched healthy controls were included for comparison.
  • Logistic regression analysis was used to calculate odds ratios (OR) and 95% confidence intervals (CI) for identified risk factors.

Main Results:

  • 62.6% of children with early wheeze developed asthma by age 11.
  • Rhinovirus infection was the only common virus associated with increased asthma risk (OR 2.4).
  • Parental asthma/allergy heredity (aOR 3.4) and allergic sensitization at age 2 (aOR 3.0) were significant risk factors.
  • The highest asthma prevalence occurred in children with both rhinovirus-induced wheeze and allergic sensitization.

Conclusions:

  • Hereditary factors and allergic sensitization play a critical role in childhood asthma development.
  • Rhinoviruses appear to be associated with asthma development in genetically predisposed children.
  • Early identification of these risk factors can inform targeted interventions for asthma prevention.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
398
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
285
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K